Korean J Physiol Pharmacol.
1999 Apr;3(2):223-230.
Thyroid hormone-induced alterations of Ca2+-ATPase and phospholamban protein expression in cardiac sarcoplasmic reticulum
- Affiliations
-
- 1Department of Pharmacology, University of Ulsan College of Medicine,
388-1 Poongnap-dong, Songpa South Korea.
Abstract
-
Alterations of cardiovascular function associated with various thyroid
states have been studied. In hyperthyroidism left ventricular
contractility and relaxation velocity were increased, whereas these
parameters were decreased in hypothyroidism. The mechanisms for these
changes have been suggested to include alterations in the expression
and/or activity levels of various proteins; alpha-myosin heavy chain,
beta-myosin heavy chain, beta-receptors, the guanine nucleotide-binding
regulatory protein, and the sarcolemmal Ca2+-ATPase. All these cellular
alterations may be associated with changes in the intracellular Ca2+
concentration. The most important regulator of intracellular Ca2+
concentration is the sarcoplasmic reticulum (SR), which serves as a
Ca2+ sink during relaxation and as a Ca2+ source during contraction.
The Ca2+-ATPase and phospholamban are the most important proteins in
the SR membrane for muscle relaxation. The dephosphorylated
phospholamban inhibits the SR Ca2+-ATPase through a direct interaction,
and phosphorylation of phospholamban relieves the inhibition. In the
present study, quantitative changes of Ca2+-ATPase and phospholamban
expression and the functional consequences of these changes in various
thyroid states were investigated. The effects of thyroid hormones on
(1) SR Ca2+ uptake, (2) phosphorylation levels of phospholamban, (3) SR
Ca2+-ATPase and phospholamban protein levels, (4) phospholamban mRNA
levels were examined. Our findings indicate that hyperthyroidism is
associated with increases in Ca2+-ATPase and decreases in phospholamban
levels whereas opposite changes in these proteins occur in
hypothyroidism.